NASDAQ: GANX · Biotechnology
Over the past week, Gain Therapeutics (GANX) drew 11 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 42% bullish but is deeply split: Reddit runs 75% bullish while X sits at just 0%. Wall Street is more constructive, with 5 of 5 analysts rating GANX a buy.
There is little buzz around GANX this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from X at 0% to Reddit at 75%. No other tracker puts the two side by side.
Across 5 analysts the consensus is a Strong Buy: 5 buy calls against 0 sell, with an average 12-month price target of $7.20.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 58 points above the crowd average of 42%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 75% bullish while X sits at 0%, a 75-point spread that single-source trackers miss.
Over the 30-day window, Gain Therapeutics (GANX) buzz held subdued around 30.5 while the price drifted up 24.0% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 527K shares. Updated Aug 15, 2026. Over the last 7 trading days, GANX gained 19.1%. Buzz activity in the recent week averaged 29.9 and was variable, swinging between 14.0 and 42.8. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 7 of the 8 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for GANX and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live GANX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (5 / 0 / 0) |
| Crowd bullish (7d) | 42% |
| Avg price target | $7.20 |
| Most bullish source | Reddit, 75% |
| Most bearish source | X, 0% |
| Sentiment spread | 75 pts |
| Mentions (7d) | 11 |
| Market cap | $90.4M |
| EPS · Beta | -$0.49 · 0.2 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Gain Therapeutics (GANX) currently carries an Adanos hold signal with 67/100 conviction. The current cross-source average reads 42% bullish across 3 active sources. Those sources contribute 11 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Gain Therapeutics (GANX) is fairly quiet with 4 mentions over the last 7 days; the 30-day context spans 4 tracked subreddits. The 7-day tone is 75% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Gain Therapeutics (GANX), averaging 42% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 75% bullish and X at 0%, a 75-point spread. On the professional side, 5 of 5 analysts rate GANX a buy.
Of the 5 analysts covering Gain Therapeutics (GANX), 5 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $7.20. That puts the street ahead of the crowd, which averages 42% bullish.
Gain Therapeutics (GANX)'s cross-source average is bearish at 42% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. Reddit reads 75% bullish, News reads 50% bullish and x coverage is the most negative at 0% bullish. The combined signal points to broad mixed pressure with 67/100 conviction.
The cross-source average is bearish for Gain Therapeutics (GANX) at 42% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. The most bearish reading is x at 0% bullish. 3-day activity momentum is rising across News. The hold signal carries 67/100 conviction.
News is the dominant discussion channel with 6 mentions (55% of total volume). Reddit contributes 4 mentions and X contributes 1 mention. The cross-source average is bearish at 42% bullish, while news is the only source with rising 3-day activity. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. GANX's hold signal at 67/100 conviction reflects a bearish cross-source average at 42% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The GANX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key